HRT Financial’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-29,231
Closed -$64K 2705
2025
Q1
$64K Buy
+29,231
New +$64K ﹤0.01% 1980
2024
Q4
Sell
-426,817
Closed -$849K 2522
2024
Q3
$849K Buy
+426,817
New +$849K ﹤0.01% 1228
2024
Q1
Sell
-199,908
Closed -$339K 2486
2023
Q4
$339K Buy
+199,908
New +$339K ﹤0.01% 1431
2023
Q2
Sell
-547,365
Closed -$826K 2594
2023
Q1
$826K Buy
547,365
+107,981
+25% +$163K 0.01% 985
2022
Q4
$1.1M Buy
439,384
+58,943
+15% +$147K 0.02% 842
2022
Q3
$1.61M Buy
+380,441
New +$1.61M 0.02% 665
2022
Q1
Sell
-37,662
Closed -$343K 3111
2021
Q4
$343K Buy
+37,662
New +$343K ﹤0.01% 1940